“Making specialty medicines accessible to all”
We manufacture and market affordable medicines that comply with global standards and strive to achieve market leadership in domestic and international markets.
LEO launched the 1st generic version of Oseltamivir Capsules – in the United States in collaboration with our marketing partner, Alvogen during the flu season in December 2016. LEO, being the only generic player during this flu season, makes this launch a notable blockbuster!
Our products cover three main markets; international formulations, domestic formulations and APIs. Within these areas we are leaders in generic oncology and are taking steps to expand therapeutic segments with a continued focus on niche products.